全文获取类型
收费全文 | 6941篇 |
免费 | 425篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 238篇 |
妇产科学 | 281篇 |
基础医学 | 719篇 |
口腔科学 | 257篇 |
临床医学 | 562篇 |
内科学 | 1345篇 |
皮肤病学 | 124篇 |
神经病学 | 280篇 |
特种医学 | 432篇 |
外科学 | 959篇 |
综合类 | 343篇 |
一般理论 | 4篇 |
预防医学 | 344篇 |
眼科学 | 469篇 |
药学 | 638篇 |
2篇 | |
中国医学 | 63篇 |
肿瘤学 | 319篇 |
出版年
2023年 | 32篇 |
2022年 | 122篇 |
2021年 | 245篇 |
2020年 | 111篇 |
2019年 | 120篇 |
2018年 | 200篇 |
2017年 | 153篇 |
2016年 | 198篇 |
2015年 | 203篇 |
2014年 | 276篇 |
2013年 | 333篇 |
2012年 | 552篇 |
2011年 | 461篇 |
2010年 | 337篇 |
2009年 | 280篇 |
2008年 | 369篇 |
2007年 | 378篇 |
2006年 | 380篇 |
2005年 | 301篇 |
2004年 | 257篇 |
2003年 | 232篇 |
2002年 | 196篇 |
2001年 | 92篇 |
2000年 | 100篇 |
1999年 | 85篇 |
1998年 | 119篇 |
1997年 | 105篇 |
1996年 | 95篇 |
1995年 | 88篇 |
1994年 | 52篇 |
1993年 | 76篇 |
1992年 | 37篇 |
1991年 | 45篇 |
1990年 | 40篇 |
1989年 | 59篇 |
1988年 | 66篇 |
1987年 | 53篇 |
1986年 | 48篇 |
1985年 | 43篇 |
1984年 | 33篇 |
1983年 | 30篇 |
1982年 | 19篇 |
1978年 | 19篇 |
1977年 | 24篇 |
1959年 | 22篇 |
1958年 | 29篇 |
1957年 | 19篇 |
1956年 | 30篇 |
1955年 | 42篇 |
1954年 | 35篇 |
排序方式: 共有7424条查询结果,搜索用时 296 毫秒
121.
人芽囊原虫在不同培养基中生长状况的观察 总被引:2,自引:1,他引:2
目的筛选培养人芽囊原虫的最适培养基。方法将同一株人芽囊原虫阳性粪便标本以2×105细胞/管接种至RPMI1640、199和LES培养基中,加入20%小牛血清及青、链霉素,pH值为7.5,放置厌氧罐中于37℃恒温培养,每24h计数,每6d转种1次。观察人芽囊原虫在3种培养基中的存活时间、虫体密度和虫体形态。结果人芽囊原虫在RPMI1640培养基中存活时间最长、虫体密度最高,虫体以空泡型多见;在LES培养基中存活时间最短、虫体密度最低,但虫体形态清晰、规则;在199培养基中存活时间和虫体密度均介于前两者之间。结论RPMI1640培养基适宜人芽囊原虫的生长繁殖,为人芽囊原虫体外培养的首选培养基;LES培养基中虫体形态清晰、规则,可用于人芽囊原虫的形态学研究;199培养基也可用于人芽囊原虫的体外培养,但不作为首选。 相似文献
122.
123.
The regulation of erythropoiesis is primarily controlled by erythropoietin (Ep). Recently, however, other factors that both stimulate and inhibit erythropoiesis have been reported. Using an in vitro liquid culture of bone marrow cells, a factor in normal mouse serum was demonstrated that markedly stimulated heme synthesis by marrow erythroid cells. In this study, the role of this heme synthesis stimulating factor (HSF) and Ep in the erythropoietic suppression caused by endotoxin administration to mice was examined. Although HSF levels did not alter appreciably after endotoxin injection, marrow erythroid cells from these animals became unresponsive to the factor. This could be reversed if Ep was added to the culture in vitro or if the hormone was injected into the mice 18 hr prior to harvesting the marrow. This marrow erythroid cell response is identical to that seen in animals in whom Ep levels are markedly reduced, such as that found in exhypoxic polycythemia, and suggest a decrease in the hormone following endotoxin administration. Additional studies demonstrated that when Ep was injected into mice 6 hr after endotoxin administration, an increase in femoral erythroid colony-forming units (CFU-E), proerythroblast number, and 59 Fe incorporation into femoral marrow cells could be demonstrated. These findings, together with the marrow erythroid cell response to the hormone, suggest that the mechanism for suppression of erythropoiesis after endotoxin injection is a reduction in the level of circulating Ep. 相似文献
124.
Lorenzo Fuccio Douglas Rex Thierry Ponchon Leonardo Frazzoni Mário Dinis-Ribeiro Pradeep Bhandari Evelien Dekker Maria Pellisè Loredana Correale Jeanin van Hooft Rodrigo Jover Diogo Libanio Franco Radaelli Sergio Alfieri Franco Bazzoli Carlo Senore Jaroslaw Regula Thomas Seufferlein Cesare Hassan 《Gastroenterology》2019,156(5):1309-1323.e3
125.
Kisucka J Chauhan AK Patten IS Yesilaltay A Neumann C Van Etten RA Krieger M Wagner DD 《Circulation research》2008,103(6):598-605
The peroxiredoxin (Prdx) family of antioxidant enzymes uses redox-active cysteines to reduce peroxides, lipid hydroperoxides, and peroxynitrites. Prdx1 is known to be important to protect red blood cells against reactive oxygen species and in tumor prevention. In this study, the role of Prdx1 in inflammation, thrombosis, and atherosclerosis was investigated. Using intravital microscopy, we showed that the number of leukocytes rolling per minute in unstimulated veins was increased by 2.5-fold in Prdx1(-/-) compared to Prdx1(+/+) mice. In Prdx1(-/-) mice, 50% of leukocytes rolled at a velocity <10 mum/sec compared with 10% in Prdx1(+/+) mice, suggesting that adhesion molecule density on the endothelium may have been increased by Prdx1 deficiency. Indeed, endothelial P-selectin, soluble P-selectin, and von Willebrand factor in plasma were increased in Prdx1(-/-) mice compared to Prdx1(+/+) mice, indicating elevated Weibel-Palade body release. In contrast to this excessive endothelial activation, Prdx1(-/-) platelets showed no sign of hyperreactivity, and their aggregation both in vitro and in vivo was normal. We also examined the role of Prdx1 in the apoE(-/-) murine spontaneous model of atherosclerosis. Prdx1(-/-)/apoE(-/-) mice fed normal chow developed larger, more macrophage-rich aortic sinus lesions than Prdx1(+/+)/apoE(-/-) mice, despite similar amounts and size distributions of cholesterol in their plasma lipoproteins. Thus, Prdx1 protects against excessive endothelial activation and atherosclerosis, and the Prdx1(-/-) mice could serve as an animal model susceptible to chronic inflammation. 相似文献
126.
Scotland RS Madhani M Chauhan S Moncada S Andresen J Nilsson H Hobbs AJ Ahluwalia A 《Circulation》2005,111(6):796-803
127.
Characterizing Longitudinal Changes in Physical Activity and Fear of Falling after Falls in Glaucoma
128.
Anil Rana Jimi Marin Alex Monika Chauhan Gaurav Joshi Raj Kumar 《Medicinal chemistry research》2015,24(3):903-920
Past few decades have witnessed the dawn of new diseases in which cancer is a major problem and the race ensued to eradicate cancer by charting out various effective therapeutic regimens. Circumventing resistance issues and combating the toxicity and selectivity problems are matter-of-concern in cancer treatment. Persistent failure to ensure complete remission and eradication of cancer instigated the researchers to exploit the strategies of combining pharmacophores as targeted therapeutic agents. Momentous improvement in the pharmacokinetic as well as pharmacodynamic profile resulting in the enhancement of bioavailability was seen with the introduction of these pharmacophores. The scope of molecular hybridization can be clearly exemplified through the US-FDA approved estramustine and others such as CUDC-101, CBLC-137, PLX3397, E-3810, and CUDC-907 that are currently in different phases of clinical trials. This review seeks to highlight and discuss anti-proliferative activity of some important hybrid, dual, and multi-targeted pharmacophores reported to date along with their designs, structure activity relationships, scope, and limitations. Further, an emphasis has been made to summarize US-FDA approved as well as drugs currently undergoing clinical trials of anticancer drug development. 相似文献
129.
130.
Rebecca Clark-Elford Pradeep J. Nathan Bonnie Auyeung Karin Mogg Brendan P. Bradley Akeem Sule Ulrich Müller Robert B. Dudas Barbara J. Sahakian Simon Baron-Cohen 《The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)》2015,18(2)